|Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing|
J Zhang, J Fujimoto, J Zhang, DC Wedge, X Song, J Zhang, S Seth, ...
Science 346 (6206), 256-259, 2014
|Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial|
AT Shaw, L Gandhi, S Gadgeel, GJ Riely, J Cetnar, H West, DR Camidge, ...
The lancet oncology 17 (2), 234-242, 2016
|Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component.|
JC Yang, MJ Ahn, DW Kim, SS Ramalingam, LV Sequist, S Wc, SW Kim, ...
Journal of Clinical Oncology, 1288-1296, 2017
|Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer|
M Reck, A Luft, A Szczesna, L Havel, SW Kim, W Akerley, MC Pietanza, ...
Journal of Clinical Oncology 34 (31), 3740-3748, 2016
|Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial|
SN Gettinger, LA Bazhenova, CJ Langer, R Salgia, KA Gold, R Rosell, ...
The lancet oncology 17 (12), 1683-1696, 2016
|Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it|
KA Hutcheson, MK Bhayani, BM Beadle, KA Gold, EH Shinn, SY Lai, ...
JAMA otolaryngology–head & neck surgery 139 (11), 1127-1134, 2013
|Targeted therapies in squamous cell carcinoma of the head and neck|
KA Gold, HY Lee, ES Kim
Cancer: Interdisciplinary International Journal of the American Cancer†…, 2009
|Relationship between tumor size and survival in non–small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry|
J Zhang, KA Gold, HY Lin, SG Swisher, Y Xing, JJ Lee, ES Kim, ...
Journal of Thoracic Oncology 10 (4), 682-690, 2015
|Exploratory analysis of brigatinib activity in patients with anaplastic lymphoma kinase-positive non–small-cell lung cancer and brain metastases in two clinical trials|
DR Camidge, DW Kim, M Tiseo, CJ Langer, MJ Ahn, AT Shaw, RM Huber, ...
Journal of Clinical Oncology 36 (26), 2693-2701, 2018
|Selective antitumor activity of ibrutinib in EGFR-mutant non–small cell lung cancer cells|
W Gao, M Wang, L Wang, H Lu, S Wu, B Dai, Z Ou, L Zhang, JV Heymach, ...
Journal of the National Cancer Institute 106 (9), dju204, 2014
|Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non–small-cell lung cancer after neoadjuvant chemotherapy|
WN William Jr, A Pataer, N Kalhor, AM Correa, DC Rice, II Wistuba, ...
Journal of Thoracic Oncology 8 (2), 222-228, 2013
|Probing the building blocks of eumelanins using scanning electron microscopy|
JB Nofsinger, SE Forest, LM Eibest, KA Gold, JD Simon
Pigment Cell Research 13 (3), 179-184, 2000
|Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: a single‐arm phase 2 clinical trial|
KA Gold, MS Kies, WN William Jr, FM Johnson, JJ Lee, BS Glisson
Cancer 124 (10), 2169-2173, 2018
|Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional TherapeuticsImmune Modulation in HNSCC by Conventional Therapies|
S Miyauchi, SS Kim, J Pang, KA Gold, JS Gutkind, JA Califano, LK Mell, ...
Clinical Cancer Research 25 (14), 4211-4223, 2019
|Safety and efficacy of brigatinib (AP26113) in advanced malignancies, including ALK+ non–small cell lung cancer (NSCLC).|
DR Camidge, L Bazhenova, R Salgia, CJ Langer, KA Gold, R Rosell, ...
Journal of Clinical Oncology 33 (15_suppl), 8062-8062, 2015
|Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: An open-label, multi-arm, non-randomised, multicentre, phase 2 trial|
AG Sacco, R Chen, FP Worden, DJL Wong, D Adkins, P Swiecicki, ...
The Lancet Oncology 22 (6), 883-892, 2021
|Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma|
Y Xing, J Zhang, H Lin, KA Gold, EM Sturgis, AS Garden, JJ Lee, ...
Cancer 122 (4), 534-545, 2016
|Safety and efficacy of pembrolizumab with chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a phase IB study|
SF Powell, KA Gold, MM Gitau, CJ Sumey, MM Lohr, SC McGraw, ...
Journal of Clinical Oncology 38 (21), 2427, 2020
|The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL|
C Ungewiss, ZH Rizvi, JD Roybal, DH Peng, KA Gold, DH Shin, ...
Scientific reports 6 (1), 18652, 2016
|Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.|
PA Jšnne, C Baik, WC Su, ML Johnson, H Hayashi, M Nishio, DW Kim, ...
Cancer discovery 12 (1), 74-89, 2021